Institutional investors purchased a net $1.5 million shares of MRNA during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 48.61% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD & CO. Bought 20.4 Million shares of Moderna Inc
D. E. SHAW & CO. LP Bought 2.3 Million shares of Moderna Inc
RENAISSANCE TECHNOLOGIES LLC Bought 1.8 Million shares of Moderna Inc